Acer Therapeutics Reports Q1 Loss Per Share $0.79

May 14 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q1 LOSS PER SHARE $0.79.Q1 EARNINGS PER SHARE ESTIMATE $-0.82 -- REFINITIV IBES DATA.ENDED Q1 WITH $31.8 MILLION IN CASH AND CASH EQUIVALENTS.BELIEVES CASH AND CASH EQUIVALENTS SUFFICIENT TO FUND ITS CURRENT OPERATING AND CAPITAL REQUIREMENTS INTO FIRST HALF OF 2020.